Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease

BACKGROUND: Infliximab therapy during pregnancy in inflammatory bowel disease is challenged by a dilemma between maintaining adequate maternal disease control while minimizing fetal infliximab exposure. We investigated the effects of pregnancy on infliximab pharmacokinetics. METHODS: The study popul...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:United European Gastroenterol J
Main Authors: Grišić, Ana‐Marija, Dorn‐Rasmussen, Maria, Ungar, Bella, Brynskov, Jørn, Ilvemark, Johan F. K. F., Bolstad, Nils, Warren, David J., Ainsworth, Mark A., Huisinga, Wilhelm, Ben‐Horin, Shomron, Kloft, Charlotte, Steenholdt, Casper
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Inflammatory Bowel Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8259366/
https://ncbi.nlm.nih.gov/pubmed/33079627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620964619
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados